NASDAQ:ENOB
Delisted
Enochian Biosciences Inc. Stock News
$0.700
+0 (+0%)
At Close: Nov 24, 2023
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
07:00am, Tuesday, 20'th Jul 2021
Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences' Scientific Approach Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affir
Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program
08:37am, Monday, 12'th Jul 2021
Enochian BioSciences Inc (NASDAQ: ENOB) has announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a potential cure of hepatitis B virus (HBV) infection. Written comme
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
07:00am, Monday, 12'th Jul 2021
LOS ANGELES, July 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
07:00am, Wednesday, 30'th Jun 2021
LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today
Enochian Biosciences: A Follow Through For An HIV Cure
02:28am, Saturday, 26'th Jun 2021
Enochian Biosciences: A Follow Through For An HIV Cure
Why Enochian BioSciences Was a Winner on Monday
05:31pm, Monday, 21'st Jun 2021
The company scores an exclusive license for new potential coronavirus treatment technology.
Enochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology
08:03am, Monday, 21'st Jun 2021
Enochian BioSciences Inc (NASDAQ: ENOB) has acquired an exclusive license for a technology to potentially treat and prevent all variants of coronavirus, including the cause of COVID-19, as well as
Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV
09:05am, Tuesday, 15'th Jun 2021
LOS ANGELES, June 15, 2021 /PRNewswire/ -- (NASDAQ: ENOB) – A promising cure for HIV is moving one step closer to FDA approval. The novel approach to treating HIV in humans using cell therapy, dev
ENOB Stock Price Increased 53.97%: Why It Happened
07:32am, Tuesday, 15'th Jun 2021
The stock price of Enochian Biosciences Inc (NASDAQ: ENOB) increased by 53.97%. This is why it happened.
Here's Why Enochian BioSciences Stock Skyrocketed Today
03:15pm, Monday, 14'th Jun 2021
The biotech's experimental treatment for HIV could be a game changer.
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
02:53pm, Monday, 14'th Jun 2021
LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today
ENOB Stock: The HIV Treatment News That Has Enochain Biosciences Skyrocketing Today
01:51pm, Monday, 14'th Jun 2021
Shares of ENOB stock are taking off on Monday after Enochain Biosciences received FDA acceptance for its vital HIV treatment. The post ENOB Stock: The HIV Treatment News That Has Enochain Biosciences
ENOB Stock Price: Over 140% Increase Pre-Market Details
09:02am, Monday, 14'th Jun 2021
The stock price of Enochian Biosciences Inc (NASDAQ: ENOB) increased by over 140% pre-market. These are the details.
Hot Penny Stocks For Your Weekly Watchlist in June
08:54am, Monday, 14'th Jun 2021
Making a penny stocks watchlist this week? Check these 3 small-caps out The post Hot Penny Stocks For Your Weekly Watchlist in June appeared first on Penny Stocks to Buy, Picks, News and Information |
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
07:00am, Monday, 14'th Jun 2021
LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the
